Valorisations sectorielles Arbutus Biopharma Corporation
Actions
ABUS
CA03879J1003
Equipement et technologie médicale avancés
|
Marché Fermé -
Nasdaq
22:00:00 21/08/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 5,210 USD | +9,22% |
|
+11,56% | +8,32% |
| 21/08 | Arbutus Biopharma Corporation envisage de lancer un programme de rachat d'actions. | CI |
| 21/08 | Arbutus Biopharma Corporation autorise un plan de rachat d'actions. | CI |
Principaux concurrents
Ajouter à une liste 0 sélectionné | PER (Y) | Price to Book (Y) | PEG (Y) | VE / CA (Y) | VE / EBITDA (Y) | VE / EBIT (Y) | Rendement du dividende (Y) | Capi.($) | |
|---|---|---|---|---|---|---|---|---|---|
| 6.99x | - | -0.01x | - | - | - | - | 1,03 Md | ||
| 38.75x | 4.95x | 2.2x | 9.06x | 20.11x | 20.5x | -.--% | 40,27 Md | ||
| 106.88x | 35.69x | -5.99x | 58.18x | 73.85x | 76.39x | 0,49% | 14,35 Md | ||
| 81.68x | 20.61x | 5.06x | 12.05x | 52.3x | 60.52x | 0,72% | 5,66 Md | ||
| -59.05x | 15.51x | 0.8x | 16.75x | -109.64x | -89.79x | - | 4,33 Md | ||
| -6.91x | - | 0.13x | 61.72x | -6.99x | -6.46x | - | 2,07 Md | ||
| 36.18x | - | 0.02x | - | - | - | -.--% | 1,62 Md | ||
| -139.84x | - | 10.79x | - | - | - | - | 1,18 Md | ||
| -72.3x | 93.64x | 8.33x | 1050.11x | -98.03x | -85.23x | -.--% | 819 M | ||
| 115x | 1.35x | -1.03x | - | - | - | 1,16% | 795 M | ||
| -9.22x | - | 0.47x | - | - | - | - | 736 M | ||
| 22.94x | 7x | 1.13x | 4.53x | 9.88x | 17.91x | 2,18% | 651 M | ||
| 52.86x | - | - | - | - | - | 1,08% | 561 M | ||
| -6x | 1.55x | 0.07x | 0.51x | 10.59x | 15.06x | -.--% | 536 M | ||
| 43.81x | - | -0.39x | - | - | - | - | 372 M | ||
| 43.79x | - | 0.52x | 3.15x | 12.09x | 12.96x | - | 371 M | ||
| -29.51x | 1.96x | 0.43x | - | - | - | - | 356 M | ||
| Moyenne | 13,30x | 20,25x | 1,41x | 135,12x | -3,98x | 2,43x | 0,63% | 4,45 Md | |
| Moyenne pondérée par Capi. | 43,27x | 14,45x | 0,74x | 33,78x | 23,36x | 26,31x | 0,22% |
- Bourse
- Actions
- Action ABUS
- Secteur Arbutus Biopharma Corporation
- Valorisations sectorielles
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
















